Following a 20+ year career as a senior leader in the pharmaceutical industry, most recently as Vice President of Genentech Research and Early Development, where he led the Safety Assessment organization and chaired their Development Review Committee, Greg is currently Owner and Principal of Cosma Biopharma Consulting, LLC. Greg also serves on Scientific Advisory Boards of biopharma companies, providing strategic guidance for portfolio decision making. Greg has led efforts across both R&D that have resulted in numerous successful approvals of currently marketed drugs, spanning diverse therapeutic areas and modalities. He is widely regarded as a trusted and transformative thought leader in the industry, applying disruptive strategies to enhance and accelerate pipeline delivery and efficiency.